• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    GCC Depression Screening Mental Health Market

    ID: MRFR/HC/54520-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    GCC Depression Screening Mental Health Market Research Report By Indication (Major Depressive Disorder, Anxiety Distress, Bipolar Disorder, Psychotic Disorders, Others), By Diagnosis (Psychological Tests, Blood Tests, Pharmacogenomic Testing, Others) and By End User (Hospitals and Clinics, Home-based, Research and Academic Institutes)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    GCC Depression Screening Mental Health Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    GCC Depression Screening Mental Health Market Summary

    The GCC Depression Screening Mental Health market is projected to grow significantly from 17.2 USD Million in 2024 to 45 USD Million by 2035.

    Key Market Trends & Highlights

    GCC Depression Screening Mental Health Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 9.11% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 45 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 17.2 USD Million, reflecting the current demand for depression screening solutions.
    • Growing adoption of mental health technologies due to increased awareness of mental health issues is a major market driver.

    Market Size & Forecast

    2024 Market Size 17.2 (USD Million)
    2035 Market Size 45 (USD Million)
    CAGR (2025-2035) 9.11%

    Major Players

    Mayo Clinic, Saudi German Health, Ibn Sina National College for Medical Studies, Qatar University, Cleveland Clinic Abu Dhabi, King Faisal Specialist Hospital & Research Centre, Medcare Hospitals, Al Ain Hospital, Hope Center for Mental Health, Aster DM Healthcare, Dubai Healthcare City, Oman Medical Specialty Centre, Seha

    GCC Depression Screening Mental Health Market Trends

    Opportunities to be explored in this market include the adoption of digital health solutions such as teletherapy and mental health apps, which facilitate easier access to screening and support.The penetration of technology into healthcare is particularly relevant in the GCC, where there is high smartphone usage and a push towards health innovation. Additionally, collaboration between government bodies and private mental health organizations can enhance screening programs, allowing for integrated care models that target various demographics. Recent trends show that there is an increasing focus on preventive measures and early interventions in mental health care.

    Awareness campaigns, which have been amplified by social media, are contributing to a cultural shift towards recognizing and addressing depression proactively. 

    Moreover, workplace wellness programs are increasingly incorporating mental health screenings, reflecting a broader understanding of the impact of mental health on productivity and overall well-being in the workplace.As the GCC continues to navigate these changes, the emphasis on comprehensive mental health services is likely to pave the way for a more supportive and informed environment for depression screening in the region.

    GCC Depression Screening Mental Health Market Drivers

    Market Segment Insights

    GCC Depression Screening Mental Health Market Segment Insights

    GCC Depression Screening Mental Health Market Segment Insights

    Depression Screening Mental Health Market Indication Insights

    Depression Screening Mental Health Market Indication Insights

    In the GCC Depression Screening Mental Health Market, the Indication segment plays a pivotal role in addressing the mental health landscape of the region. As mental health awareness grows, there is an increasing demand for effective screening methods to identify indications of various disorders. Major Depressive Disorder is notably prevalent, significantly impacting overall quality of life and workforce productivity.

    The increasing rate of stress and lifestyle changes within the GCC exacerbates this condition, placing it at the forefront of mental health concerns.Anxiety Distress is another major aspect affecting large segments of the population due to factors such as economic fluctuations and social dynamics, highlighting the necessity for assessment tools for early detection and intervention. 

    Bipolar Disorder, while less common, poses unique challenges due to its complex nature, often requiring specialized screening techniques for accurate identification, underscoring its significance within the market. Psychotic Disorders also contribute to the complexities of mental health in the GCC, necessitating comprehensive solutions that account for cultural and social factors in diagnosis.Additionally, the category labeled Others encapsulates a range of conditions, providing a holistic view of mental health challenges that may not fit neatly into established diagnostic criteria.

    The GCC's integration of mental health services in healthcare policies indicates a trend towards prioritizing mental well-being, supported by government initiatives aimed at reducing stigma and increasing accessibility to mental health care. 

    Depression Screening Mental Health Market Diagnosis Insights

    Depression Screening Mental Health Market Diagnosis Insights

    The Diagnosis segment of the GCC Depression Screening Mental Health Market focuses on effective and reliable methods to identify depression among individuals, which is crucial given the rising mental health concerns in the region. Psychological Tests dominate this segment, as they are essential for assessing mental health states and facilitating proper interventions. Blood Tests are gaining attention due to advancements in biological markers that may assist in understanding depressive disorders more comprehensively. Similarly, Pharmacogenomic Testing holds significant importance as it can provide insights into how individuals metabolize medications, leading to more personalized treatment options.

    Other methods also contribute to this segment by incorporating various innovative diagnostic tools that cater to the diverse population in the GCC. The increasing awareness of mental health issues, along with supportive government initiatives, is driving the demand for enhanced diagnosis solutions, making this segment critical for improving overall mental health outcomes in the region. The evolving trends in diagnostic methodologies highlight the necessity for continuous development and adaptation as a response to the growing mental health challenges faced by the population in the GCC.

    Depression Screening Mental Health Market End User Insights

    Depression Screening Mental Health Market End User Insights

    The End User segment of the GCC Depression Screening Mental Health Market plays a crucial role in addressing the rising mental health issues across the region. Hospitals and clinics are critical as they provide the frontline services for depression screening, equipped with the necessary tools and trained professionals to diagnose and treat patients effectively. Home-based care is gaining traction as it allows for personalized treatment in familiar surroundings, enabling better adherence to screening protocols and follow-up care. 

    Meanwhile, research and academic institutes are pivotal in driving innovation and understanding of mental health, conducting studies that inform best practices and potentially public policy.The growing focus on mental health awareness in the GCC, supported by governmental initiatives, has created significant opportunities within these End ser segments. Enhanced accessibility to services, combined with an increasing emphasis on early screening, contributes to the market's potential growth. 

    Overall, the diversity within the End User segment reflects a comprehensive approach to mental health, aiming to address the unique needs of different populations across the GCC.

    Get more detailed insights about GCC Depression Screening Mental Health Market Research Report - Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The GCC Depression Screening Mental Health Market has emerged as a critical focus area within the broader mental health landscape, as growing awareness of mental health issues and increasing government initiatives aim to reduce the stigma associated with seeking help. In this market, various organizations are competing to provide innovative screening tools, therapies, and integrated health solutions to meet the diverse needs of patients experiencing depression.

    As the demand for mental health services continues to rise due to factors such as urbanization, lifestyle changes, and the impacts of recent global health crises, players within this sector are leveraging advanced technologies and developing evidence-based approaches to screening and treatment. 

    The competitive landscape is characterized by prominent healthcare providers, research institutions, and telehealth platforms, all striving to enhance the quality and accessibility of depression screening services across the GCC.Focusing on the strengths of Mayo Clinic within the GCC Depression Screening Mental Health Market, the organization has an established reputation for clinical excellence and a patient-centered approach that prioritizes evidence-based care. Their commitment to research and continuous improvement allows them to consistently integrate innovative assessment methods and tools into their mental health services.

    With a robust network of specialists and healthcare professionals, Mayo Clinic is well-positioned to address the diverse needs of individuals suffering from depression in the GCC region. 

    Their experience in collaborative care models enhances their effectiveness in the diagnosis and management of depression, while their ongoing medical education initiatives contribute to raising mental health awareness and training within the local community.Saudi German Health has also made significant strides in the GCC Depression Screening Mental Health Market by offering a comprehensive range of services aimed at addressing mental health issues, including depression. With a strong emphasis on quality healthcare, Saudi German Health provides various programs and services such as consultations, psychological assessments, and therapeutic interventions tailored to the needs of their patients.

    The organization benefits from its extensive hospital network across the GCC, which aids in the accessibility of its mental health services. 

    The strengths of Saudi German Health in this arena include their collaboration with renowned mental health professionals and institutions, which support the exchange of knowledge and best practices. Additionally, their strategic partnerships and potential mergers and acquisitions focus on expanding their service offerings and enhancing clinical capabilities. By constantly adapting to the evolving healthcare landscape and integrating advanced technologies, Saudi German Health is positioning itself as a leader in depression screening and mental health support within the region.

    Key Companies in the GCC Depression Screening Mental Health Market market include

    Industry Developments

    Recent developments in the GCC Depression Screening Mental Health Market indicate a significant shift toward enhanced mental health services across the region. Investments in mental health initiatives have surged, with institutions such as Cleveland Clinic Abu Dhabi and King Faisal Specialist Hospital and Research Centre expanding their mental health services. In November 2022, Saudi German Health announced the opening of a new mental health facility, enhancing accessibility to depression screening and treatment. Moreover, Aster DM Healthcare has been focusing on integrating innovative technologies in mental health screenings. 

    Recent growth in market valuations, attributed to increased awareness and government support for mental health, has positively influenced the sector. In September 2023, Hope Center for Mental Health launched a collaborative program with Qatar University aimed at advancing research in depression treatment methods. Furthermore, Medcare Hospitals have expanded their outreach programs to increase awareness and accessibility mental health resources within the community. The GCC region demonstrates a strong commitment to addressing mental health issues, with ongoing efforts to integrate mental health into primary healthcare systems and foster collaborations among healthcare providers.

    Market Segmentation

    Outlook

    • Hospitals and Clinics
    • Home-based
    • Research and Academic Institutes

    Report Scope

     
    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 17.24(USD Million)
    MARKET SIZE 2024 18.25(USD Million)
    MARKET SIZE 2035 45.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 8.55% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Mayo Clinic, Saudi German Health, Ibn Sina National College for Medical Studies, Qatar University, Cleveland Clinic Abu Dhabi, King Faisal Specialist Hospital & Research Centre, Medcare Hospitals, Al Ain Hospital, Hope Center for Mental Health, Aster DM Healthcare, S amet, Dubai Healthcare City, Oman Medical Specialty Centre, Seha
    SEGMENTS COVERED Indication, Diagnosis, End User
    KEY MARKET OPPORTUNITIES Telehealth service adoption, Increased awareness initiatives, Government mental health funding, Advanced screening technologies, Collaborations with local NGOs
    KEY MARKET DYNAMICS increasing prevalence of depression, rising awareness of mental health, advancements in screening technologies, government mental health initiatives, growing telehealth adoption
    COUNTRIES COVERED GCC

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the GCC Depression Screening Mental Health Market in 2024?

    The expected market size of the GCC Depression Screening Mental Health Market in 2024 is valued at 18.25 million USD.

    What will be the growth rate of the GCC Depression Screening Mental Health Market from 2025 to 2035?

    The expected compound annual growth rate (CAGR) for the GCC Depression Screening Mental Health Market from 2025 to 2035 is 8.55%.

    What will be the market size of the GCC Depression Screening Mental Health Market in 2035?

    In 2035, the overall market is projected to reach a value of 45.0 million USD.

    Which indication holds the largest market share in the GCC Depression Screening Mental Health Market in 2024?

    Major Depressive Disorder holds the largest market share in the GCC Depression Screening Mental Health Market, valued at 8.0 million USD in 2024.

    What is the expected market size for Anxiety Distress within the GCC Depression Screening Mental Health Market in 2035?

    The expected market size for Anxiety Distress within the GCC Depression Screening Mental Health Market is projected to be 10.0 million USD in 2035.

    How much is the GCC Depression Screening Mental Health Market for Bipolar Disorder expected to be valued in 2025?

    The market for Bipolar Disorder in the GCC Depression Screening Mental Health Market is expected to continue growing towards 6.5 million USD by 2035.

    Who are some of the key players in the GCC Depression Screening Mental Health Market?

    Key players in the GCC Depression Screening Mental Health Market include Mayo Clinic, Saudi German Health, and Cleveland Clinic Abu Dhabi, among others.

    What is the projected market size for Psychotic Disorders in the GCC Depression Screening Mental Health Market by 2035?

    The projected market size for Psychotic Disorders within the GCC Depression Screening Mental Health Market is expected to reach 4.5 million USD by 2035.

    What are the growth drivers for the GCC Depression Screening Mental Health Market?

    Growth drivers for the GCC Depression Screening Mental Health Market include increasing awareness of mental health issues and rising demand for screening services.

    How does the GCC region's mental health market compare to other regions?

    The GCC Depression Screening Mental Health Market is experiencing robust growth compared to other regions, driven by unique demographic and healthcare challenges.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. GCC
    59. Depression Screening Mental Health Market, BY Indication (USD Million)
    60. Major
    61. Depressive Disorder
    62. Anxiety Distress
    63. Bipolar
    64. Disorder
    65. Psychotic Disorders
    66. Others
    67. GCC
    68. Depression Screening Mental Health Market, BY Diagnosis (USD Million)
    69. Psychological
    70. Tests
    71. Blood Tests
    72. Pharmacogenomic
    73. Testing
    74. Others
    75. GCC
    76. Depression Screening Mental Health Market, BY End User (USD Million)
    77. Hospitals
    78. and Clinics
    79. Home-based
    80. Research
    81. and Academic Institutes
    82. Competitive Landscape
    83. Overview
    84. Competitive
    85. Analysis
    86. Market share Analysis
    87. Major
    88. Growth Strategy in the Depression Screening Mental Health Market
    89. Competitive
    90. Benchmarking
    91. Leading Players in Terms of Number of Developments
    92. in the Depression Screening Mental Health Market
    93. Key
    94. developments and growth strategies
    95. New Product Launch/Service
    96. Deployment
    97. Merger & Acquisitions
    98. Joint
    99. Ventures
    100. Major Players Financial Matrix
    101. Sales
    102. and Operating Income
    103. Major Players R&D Expenditure.
    104. Company
    105. Profiles
    106. Mayo Clinic
    107. Financial
    108. Overview
    109. Products Offered
    110. Key
    111. Developments
    112. SWOT Analysis
    113. Key
    114. Strategies
    115. Saudi German Health
    116. Financial
    117. Overview
    118. Products Offered
    119. Key
    120. Developments
    121. SWOT Analysis
    122. Key
    123. Strategies
    124. Ibn Sina National College
    125. for Medical Studies
    126. Financial Overview
    127. Products
    128. Offered
    129. Key Developments
    130. SWOT
    131. Analysis
    132. Key Strategies
    133. Qatar
    134. University
    135. Financial Overview
    136. Products
    137. Offered
    138. Key Developments
    139. SWOT
    140. Analysis
    141. Key Strategies
    142. Cleveland
    143. Clinic Abu Dhabi
    144. Financial Overview
    145. Products
    146. Offered
    147. Key Developments
    148. SWOT
    149. Analysis
    150. Key Strategies
    151. King
    152. Faisal Specialist Hospital & Research Centre
    153. Financial
    154. Overview
    155. Products Offered
    156. Key
    157. Developments
    158. SWOT Analysis
    159. Key
    160. Strategies
    161. Medcare Hospitals
    162. Financial
    163. Overview
    164. Products Offered
    165. Key
    166. Developments
    167. SWOT Analysis
    168. Key
    169. Strategies
    170. Al Ain Hospital
    171. Financial
    172. Overview
    173. Products Offered
    174. Key
    175. Developments
    176. SWOT Analysis
    177. Key
    178. Strategies
    179. Hope Center for Mental Health
    180. Financial
    181. Overview
    182. Products Offered
    183. Key
    184. Developments
    185. SWOT Analysis
    186. Key
    187. Strategies
    188. Aster DM Healthcare
    189. Financial
    190. Overview
    191. Products Offered
    192. Key
    193. Developments
    194. SWOT Analysis
    195. Key
    196. Strategies
    197. S amet
    198. Financial
    199. Overview
    200. Products Offered
    201. Key
    202. Developments
    203. SWOT Analysis
    204. Key
    205. Strategies
    206. Dubai Healthcare City
    207. Financial
    208. Overview
    209. Products Offered
    210. Key
    211. Developments
    212. SWOT Analysis
    213. Key
    214. Strategies
    215. Oman Medical Specialty Centre
    216. Financial
    217. Overview
    218. Products Offered
    219. Key
    220. Developments
    221. SWOT Analysis
    222. Key
    223. Strategies
    224. Seha
    225. Financial
    226. Overview
    227. Products Offered
    228. Key
    229. Developments
    230. SWOT Analysis
    231. Key
    232. Strategies
    233. References
    234. Related
    235. Reports
    236. LIST
    237. OF ASSUMPTIONS
    238. GCC Depression Screening Mental Health
    239. Market SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2035 (USD Billions)
    240. GCC
    241. Depression Screening Mental Health Market SIZE ESTIMATES & FORECAST, BY DIAGNOSIS,
    242. 2035 (USD Billions)
    243. GCC Depression Screening Mental
    244. Health Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    245. PRODUCT
    246. LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    247. ACQUISITION/PARTNERSHIP
    248. LIST
    249. Of figures
    250. MARKET SYNOPSIS
    251. GCC
    252. DEPRESSION SCREENING MENTAL HEALTH MARKET ANALYSIS BY INDICATION
    253. GCC
    254. DEPRESSION SCREENING MENTAL HEALTH MARKET ANALYSIS BY DIAGNOSIS
    255. GCC
    256. DEPRESSION SCREENING MENTAL HEALTH MARKET ANALYSIS BY END USER
    257. KEY
    258. BUYING CRITERIA OF DEPRESSION SCREENING MENTAL HEALTH MARKET
    259. RESEARCH
    260. PROCESS OF MRFR
    261. DRO ANALYSIS OF DEPRESSION SCREENING
    262. MENTAL HEALTH MARKET
    263. DRIVERS IMPACT ANALYSIS: DEPRESSION
    264. SCREENING MENTAL HEALTH MARKET
    265. RESTRAINTS IMPACT ANALYSIS:
    266. DEPRESSION SCREENING MENTAL HEALTH MARKET
    267. SUPPLY / VALUE
    268. CHAIN: DEPRESSION SCREENING MENTAL HEALTH MARKET
    269. DEPRESSION
    270. SCREENING MENTAL HEALTH MARKET, BY INDICATION, 2025 (% SHARE)
    271. DEPRESSION
    272. SCREENING MENTAL HEALTH MARKET, BY INDICATION, 2019 TO 2035 (USD Billions)
    273. DEPRESSION
    274. SCREENING MENTAL HEALTH MARKET, BY DIAGNOSIS, 2025 (% SHARE)
    275. DEPRESSION
    276. SCREENING MENTAL HEALTH MARKET, BY DIAGNOSIS, 2019 TO 2035 (USD Billions)
    277. DEPRESSION
    278. SCREENING MENTAL HEALTH MARKET, BY END USER, 2025 (% SHARE)
    279. DEPRESSION
    280. SCREENING MENTAL HEALTH MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    281. BENCHMARKING
    282. OF MAJOR COMPETITORS

    GCC Depression Screening Mental Health Market Segmentation

    • Depression Screening Mental Health Market By Indication (USD Million, 2019-2035)

      • Major Depressive Disorder
      • Anxiety Distress
      • Bipolar Disorder
      • Psychotic Disorders
      • Others

     

    • Depression Screening Mental Health Market By Diagnosis (USD Million, 2019-2035)

      • Psychological Tests
      • Blood Tests
      • Pharmacogenomic Testing
      • Others

     

    • Depression Screening Mental Health Market By End User (USD Million, 2019-2035)

      • Hospitals and Clinics
      • Home-based
      • Research and Academic Institutes

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials